Physio-Control, a subsidiary of Medtronic, has launched ReadyLink 12-Lead ECG device to improve care for heart attack patients and expand regional ST-segment elevation myocardial infarction (STEMI) systems.
ReadyLink helps providers of basic life support (BLS) emergency medical service (EMS) to acquire and transmit a patient’s 12-lead ECG to hospitals using Physio-Control’s Lifenet System, a cloud-based data network for remote physician interpretation and decision support.
Physio-Control product realization vice president Randy Merry said ReadyLink focuses on one activity and clinical patient condition versus the multiple clinical capabilities of an ALS monitor.
"With ReadyLink, our customers do not need to know how to interpret a heart rhythm, the only training required is how to place electrodes on a patient’s chest and transmit the 12-lead ECG," Merry said.
The ReadyLink ECG device has received the US Food and Drug Administration (FDA) 510(k) approval.